Higher Pathological Complete Response Rate of Less than 10 Total Axillary Lymph Nodes After Axillary Lymph Node Dissection Following Neoadjuvant Chemotherapy in Breast Cancer
BackgroundThe American Joint Committee on Cancer (AJCC) guideline recommends the evaluation of ≥10 axillary lymph nodes (ALN) in patients with breast cancer to assess the N stage. However, the total ALN count in ALN dissection (ALND) often decreases after neoadjuvant chemotherapy in breast cancer. T...
Main Authors: | Jeeyeon Lee, Nora Jee-Young Park, Byeongju Kang, Jin Hyang Jung, Wan Wook Kim, Yee Soo Chae, Soo Jung Lee, Hye Jung Kim, Ji-Young Park, Ho Yong Park |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2022-03-01
|
Series: | Frontiers in Surgery |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fsurg.2022.678169/full |
Similar Items
-
Feasibility of an indocyanine green-hyaluronic acid mixture (LuminoMark™) for targeting suspicious axillary lymph nodes in patients with breast cancer
by: Jeeyeon Lee, et al.
Published: (2024-12-01) -
Value of accurate diagnosis for metastatic supraclavicular lymph nodes in breast cancer: assessment with neck US, CT, and 18F-FDG PET/CT
by: Jeeyeon Lee, et al.
Published: (2021-05-01) -
Oncologic necessity for the complete removal of residual microcalcifications after neoadjuvant chemotherapy for breast cancer
by: Jeeyeon Lee, et al.
Published: (2022-12-01) -
Long non-coding RNA SOX2OT in tamoxifen-resistant breast cancer
by: Jeeyeon Lee, et al.
Published: (2024-04-01) -
The prognosis factors among breast cancer patients with extensive axillary lymph node metastasis
by: Jae-Myung Kim, et al.
Published: (2018-06-01)